Diagnostic Potential of Serum Proteomic Patterns in Prostate Cancer
- 1 August 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 170 (2), 442-446
- https://doi.org/10.1097/01.ju.0000069431.95404.56
Abstract
The serum prostate specific antigen test has been widely used in the last decade as an effective screening tool for prostate cancer (CaP). However, the high false-positive rate of the serum prostate specific antigen test necessitates the development of more accurate diagnostic and prognostic biomarkers for CaP. Promising diagnostic potential of serum protein patterns detected by surface enhanced laser desorption/ionization time of flight mass spectrometry for CaP has recently been reported. Independent evaluation of this new technology is warranted to realize its translational utility. We determined whether serum protein profiling by surface enhanced laser desorption/ionization time of flight mass spectrometry and a decision tree algorithm classification system could accurately discriminate between patients with CaP and unaffected individuals. Proteomic spectra of crude serum were generated using the Ciphergen ProteinChip System and pattern detection was performed using Biomarker Patterns Software (Ciphergen Biosystems, Inc., Fremont, California). A total of 106 patients with CaP and 56 controls were randomly allocated to a training set and a test set. The training set, which consisted of 44 patients with cancer and 30 controls, was used to build a decision tree algorithm. The test set, which consisted of 62 patients with cancer and 26 controls, was used in blinded fashion to validate the decision tree. Accuracy of classification using the test set was 67% and 42% for the weak cation exchange array and the copper metal affinity capture array, respectively. Combined spectral data from the weak cation exchange and copper metal affinity capture arrays generated an algorithm that achieved 85% sensitivity and 85% specificity for the detection of CaP. These preliminary findings support recent observations that complex protein profiles have promising potential for the early detection of CaP and warrant future studies with streamlined technology. Furthermore, the combined effect of using 2 array types can greatly enhance the ability of protein profile patterns, suggesting the potential usefulness of alternative approaches to evaluate this new emerging technology.Keywords
This publication has 14 references indexed in Scilit:
- Serum Proteomic Patterns for Detection of Prostate CancerJNCI Journal of the National Cancer Institute, 2002
- DNA Microarrays in Clinical OncologyJournal of Clinical Oncology, 2002
- Cancer genomicsCancer Cell, 2002
- Use of proteomic patterns in serum to identify ovarian cancerThe Lancet, 2002
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- A review of evidence of health benefit from artificial neural networks in medical interventionNeural Networks, 2001
- Mass spectrometry meets chip technology: A new proteomic tool in cancer research?Electrophoresis, 2001
- Prostate-Specific–Antigen Testing for Early Diagnosis of Prostate CancerNew England Journal of Medicine, 2001
- Development of a Novel Proteomic Approach for the Detection of Transitional Cell Carcinoma of the Bladder in UrineThe American Journal of Pathology, 2001
- How good are support vector machines?Neural Networks, 2000